HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+15.92%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.62B
AUM Growth
+$1.62B
(+2.2%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-10.83%
Top 10 Holdings %
Top 10 Hldgs %
47.55%
Holding
79
New
28
Increased
9
Reduced
15
Closed
20
Top Buys
| 1 |
Biogen
BIIB
|
$80.5M |
| 2 |
AET
Aetna Inc
AET
|
$74.6M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$56.2M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$54M |
| 5 |
Brookdale Senior Living
BKD
|
$52.7M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$116M |
| 2 |
Bausch Health
BHC
|
$93M |
| 3 |
Pfizer
PFE
|
$79.9M |
| 4 |
Keysight
KEYS
|
$69M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$66.5M |
Sector Composition
| 1 | Healthcare | 78.83% |
| 2 | Financials | 4.62% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Universal Health Services
UHS
$11.6B
| $26.5M | 1.26% |
225,000
-225,000
| -50% | -$26.5M |
|
27
Acadia Pharmaceuticals
ACAD
$4.34B
| $23.6M | 1.13% |
+725,000
| New | +$23.6M |
|
|
AMRI
28
DELISTED
Albany Molecular Research Inc
AMRI
| $22.4M | 1.07% |
1,275,000
-325,000
| -20% | -$5.72M |
|
29
Agilent Technologies
A
$35.5B
| $21.8M | 1.04% |
525,000
+285,500
| +119% | +$11.9M |
|
|
KYTH
30
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $21.3M | 1.02% |
425,000
+333,400
| +364% | +$16.7M |
|
|
TTPH
31
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $17.1M | 0.82% |
+23,360
| New | +$17.1M |
|
|
ARAV
32
DELISTED
Aravive, Inc. Common Stock
ARAV
| $16.9M | 0.8% |
152,933
+7,100
| +5% | +$783K |
|
33
Arbutus Biopharma
ABUS
$753M
| $12.6M | 0.6% |
+718,800
| New | +$12.6M |
|
|
AERI
34
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $11M | 0.52% |
+350,000
| New | +$11M |
|
35
Integra LifeSciences
IART
$1.18B
| $10.8M | 0.51% |
+428,133
| New | +$10.8M |
|
|
ELGX
36
DELISTED
Endologix Inc
ELGX
| $9.83M | 0.47% |
+57,580
| New | +$9.83M |
|
37
Thermo Fisher Scientific
TMO
$183B
| $9.15M | 0.44% |
68,100
-331,900
| -83% | -$44.6M |
|
|
DYAX
38
DELISTED
DYAX CORPORATION
DYAX
| $8.21M | 0.39% |
+489,900
| New | +$8.21M |
|
|
DSCI
39
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $7.57M | 0.36% |
893,600
-26,400
| -3% | -$224K |
|
|
40
Gilead Sciences
GILD
$140B
| $6.79M | 0.32% |
69,200
-1,180,800
| -94% | -$116M |
|
41
Accuray
ARAY
$165M
| $6.76M | 0.32% |
+727,000
| New | +$6.76M |
|
42
Akebia Therapeutics
AKBA
$827M
| $6.61M | 0.32% |
594,534
-250,720
| -30% | -$2.79M |
|
43
IQVIA
IQV
$31.4B
| $6.46M | 0.31% |
+96,496
| New | +$6.46M |
|
44
Assembly Biosciences
ASMB
$185M
| $6.29M | 0.3% |
+39,583
| New | +$6.29M |
|
45
Sarepta Therapeutics
SRPT
$1.98B
| $6.15M | 0.29% |
+462,700
| New | +$6.15M |
|
46
Danaher
DHR
$143B
| $5.53M | 0.26% |
96,858
+18,747
| +24% | +$1.07M |
|
47
UnitedHealth
UNH
$279B
| $4.89M | 0.23% |
+41,300
| New | +$4.89M |
|
48
CVS Health
CVS
$93B
| $4.44M | 0.21% |
+43,000
| New | +$4.44M |
|
|
ACGN
49
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $4.33M | 0.21% |
8,581
+2,632
| +44% | +$1.33M |
|
50
Cigna
CI
$80.2B
| $4.29M | 0.2% |
+33,159
| New | +$4.29M |
|